谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Comparison of Nivolumab Plus Ipilimumab with Tyrosine Kinase Inhibitors As First-Line Therapies for Metastatic Renal-Cell Carcinoma: a Multicenter Retrospective Study.

Kido Koichi,Hatakeyama Shingo,Numakura Kazuyuki,Tanaka Toshikazu,Oikawa Masaaki,Noro Daisuke,Hosogoe Shogo,Narita Shintaro,Inoue Takamitsu,Yoneyama Takahiro,Ito Hiroyuki,Nishimura Shoji,Hashimoto Yasuhiro,Kawaguchi Toshiaki,Habuchi Tomonori, Ohyama Chikara

International Journal of Clinical Oncology（2020）

引用 10|浏览42
暂无评分
关键词
Renal-cell carcinoma,Nivolumab,Ipilimumab,Tyrosine kinase inhibitors,Survival
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要